NASDAQ:MDXH MDxHealth (MDXH) Stock Price, News & Analysis $2.85 +0.01 (+0.35%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$2.86 +0.00 (+0.18%) As of 08/15/2025 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About MDxHealth Stock (NASDAQ:MDXH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MDxHealth alerts:Sign Up Key Stats Today's Range$2.75▼$2.9550-Day Range$1.97▼$2.8852-Week Range$1.35▼$3.50Volume87,150 shsAverage Volume116,008 shsMarket Capitalization$134.78 millionP/E RatioN/ADividend YieldN/APrice Target$7.00Consensus RatingBuy Company Overview MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium. Read More MDxHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks43rd Percentile Overall ScoreMDXH MarketRank™: MDxHealth scored higher than 43% of companies evaluated by MarketBeat, and ranked 680th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMDxHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMDxHealth has only been the subject of 1 research reports in the past 90 days.Read more about MDxHealth's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for MDxHealth are expected to grow in the coming year, from ($1.15) to ($0.61) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MDxHealth is -3.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MDxHealth is -3.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMDxHealth has a P/B Ratio of 9.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about MDxHealth's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.31% of the float of MDxHealth has been sold short.Short Interest Ratio / Days to CoverMDxHealth has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MDxHealth has recently increased by 53.15%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMDxHealth does not currently pay a dividend.Dividend GrowthMDxHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.31% of the float of MDxHealth has been sold short.Short Interest Ratio / Days to CoverMDxHealth has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MDxHealth has recently increased by 53.15%, indicating that investor sentiment is decreasing significantly. News and Social Media2.0 / 5News Sentiment0.53 News SentimentMDxHealth has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for MDxHealth this week, compared to 1 article on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, MDxHealth insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.70% of the stock of MDxHealth is held by insiders.Read more about MDxHealth's insider trading history. Receive MDXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address MDXH Stock News HeadlinesMdxhealth Reports Strong Q2 Growth and Strategic AcquisitionAugust 15 at 4:15 AM | msn.comMDxHealth Reports Strong Revenue Growth in 2025 Interim ResultsAugust 14 at 11:15 PM | msn.comAmerica’s Finest Hour: Sept 30After This White House Deadline, All Bets Are Off The White House just issued a sweeping order that could send U.S.-based AI stocks soaring. But there's a catch – this mandate comes with a strict September 30th deadline for federal agencies to comply. If you don't act before that, you could miss out on the biggest returns. One of Wall Street's most brilliant investment millionaires explains why in a new FREE video. | Stansberry Research (Ad)Insights Ahead: MDxHealth's Quarterly EarningsAugust 14 at 6:14 PM | benzinga.comMdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-TechneAugust 5, 2025 | globenewswire.comMDxHealth names Michael Holder to board, CFO Ron Kalfus to departJuly 5, 2025 | investing.comMDxHealth Appoints Michael Holder as Chair of Audit Committee, Announces CFO Transition - NasdaqJuly 5, 2025 | nasdaq.comMDxHealth CFO Kalfus ResignsJuly 3, 2025 | marketwatch.comSee More Headlines MDXH Stock Analysis - Frequently Asked Questions How have MDXH shares performed this year? MDxHealth's stock was trading at $2.37 at the start of the year. Since then, MDXH shares have increased by 20.3% and is now trading at $2.85. How were MDxHealth's earnings last quarter? MDxHealth SA (NASDAQ:MDXH) posted its earnings results on Tuesday, August, 5th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.02. The business had revenue of $26.60 million for the quarter, compared to analyst estimates of $26.60 million. MDxHealth had a negative trailing twelve-month return on equity of 274.67% and a negative net margin of 34.98%. Read the conference call transcript. When did MDxHealth's stock split? MDxHealth shares reverse split before market open on Friday, December 29th 2023.The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did MDxHealth IPO? MDxHealth (MDXH) raised $45 million in an IPO on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share. Who are MDxHealth's major shareholders? MDxHealth's top institutional investors include Samjo Management LLC (3.25%), Delta Investment Management LLC (0.37%) and FreeGulliver LLC (0.26%). View institutional ownership trends. How do I buy shares of MDxHealth? Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MDxHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that MDxHealth investors own include Cognition Therapeutics (CGTX), LAVA Therapeutics (LVTX), Coeptis Therapeutics (COEP), PHX Minerals (PHX), PayPal (PYPL), Arcadia Biosciences (RKDA) and Alimera Sciences (ALIM). Company Calendar Last Earnings8/05/2025Today8/15/2025Next Earnings (Estimated)8/20/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryN/A Current SymbolNASDAQ:MDXH CIK1872529 Webmdxhealth.com Phone324-364-2070Fax32042597875Employees300Year FoundedN/APrice Target and Rating Average Price Target for MDxHealth$7.00 High Price Target$8.00 Low Price Target$6.00 Potential Upside/Downside+145.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$38.07 million Net Margins-34.98% Pretax Margin-40.47% Return on Equity-274.67% Return on Assets-21.21% Debt Debt-to-Equity Ratio13.81 Current Ratio2.00 Quick Ratio1.92 Sales & Book Value Annual Sales$90.05 million Price / Sales1.50 Cash FlowN/A Price / Cash FlowN/A Book Value$0.31 per share Price / Book9.19Miscellaneous Outstanding Shares47,290,000Free Float46,484,000Market Cap$134.78 million OptionableNot Optionable Beta1.41 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:MDXH) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. Share MDxHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.